Measles, mumps, rubella (MMR) vaccine – a reply (2)
openaire +3 more sources
Measles, mumps, rubella (MMR) vaccine – a reply (1)
openaire +3 more sources
Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial. [PDF]
Habib MA +9 more
europepmc +1 more source
Live viral measles-mumps-rubella revaccination and varicella vaccination in children and adolescents with juvenile idiopathic arthritis: a systematic review. [PDF]
Dipasquale RF +3 more
europepmc +1 more source
Vitamin A and body weight status do not impact humoral immunity against measles, mumps or rubella in individuals 4 to 18 years old: a cross-sectional cohort study in India. [PDF]
Ratishvili T +9 more
europepmc +1 more source
Vaccine-Induced Immunity in Children and Adolescents After Chemotherapy for Acute Lymphoblastic Leukemia: A Systematic Review. [PDF]
Valente CFC +10 more
europepmc +1 more source
Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country. [PDF]
Chun JY +9 more
europepmc +1 more source
Letter to the Editor: Bridging the immunization gap in pediatric autoimmune disorders - insights from inflammatory bowel disease and vaccine response patterns. [PDF]
Al-Hussaniy HA.
europepmc +1 more source
Evolution and Future Directions of the National Measles Immunization Program in the Republic of Korea. [PDF]
Lee H +5 more
europepmc +1 more source
Combination Vaccines in Routine Childhood Immunization Programs - Worldwide, 2024. [PDF]
Zheng F +4 more
europepmc +1 more source

